These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 14695884)

  • 1. Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization.
    Aharoni A; Gaidukov L; Yagur S; Toker L; Silman I; Tawfik DS
    Proc Natl Acad Sci U S A; 2004 Jan; 101(2):482-7. PubMed ID: 14695884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Directed evolution of serum paraoxonase PON3 by family shuffling and ancestor/consensus mutagenesis, and its biochemical characterization.
    Khersonsky O; Rosenblat M; Toker L; Yacobson S; Hugenmatter A; Silman I; Sussman JL; Aviram M; Tawfik DS
    Biochemistry; 2009 Jul; 48(28):6644-54. PubMed ID: 19492856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes.
    Harel M; Aharoni A; Gaidukov L; Brumshtein B; Khersonsky O; Meged R; Dvir H; Ravelli RB; McCarthy A; Toker L; Silman I; Sussman JL; Tawfik DS
    Nat Struct Mol Biol; 2004 May; 11(5):412-9. PubMed ID: 15098021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase.
    Khersonsky O; Tawfik DS
    Biochemistry; 2005 Apr; 44(16):6371-82. PubMed ID: 15835926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen esters as substrates for human paraoxonases.
    Teiber JF; Billecke SS; La Du BN; Draganov DI
    Arch Biochem Biophys; 2007 May; 461(1):24-9. PubMed ID: 17412306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directed evolution of recombinant serum paraoxonase (PON) variants.
    Aharoni A; Tawfik DS
    Discov Med; 2004 Apr; 4(21):120-4. PubMed ID: 20705007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and purification of biologically active recombinant human paraoxonase 1 from inclusion bodies of Escherichia coli.
    Bajaj P; Tripathy RK; Aggarwal G; Pande AH
    Protein Expr Purif; 2015 Nov; 115():95-101. PubMed ID: 26003526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altering the substrate specificity of organophosphorus hydrolase for enhanced hydrolysis of chlorpyrifos.
    Cho CM; Mulchandani A; Chen W
    Appl Environ Microbiol; 2004 Aug; 70(8):4681-5. PubMed ID: 15294802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directed evolution of sulfotransferases and paraoxonases by ancestral libraries.
    Alcolombri U; Elias M; Tawfik DS
    J Mol Biol; 2011 Aug; 411(4):837-53. PubMed ID: 21723874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3.
    Taler-Verčič A; Goličnik M; Bavec A
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33348669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraoxonases-1, -2 and -3: What are their functions?
    Furlong CE; Marsillach J; Jarvik GP; Costa LG
    Chem Biol Interact; 2016 Nov; 259(Pt B):51-62. PubMed ID: 27238723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolutionary origins of detoxifying enzymes: the mammalian serum paraoxonases (PONs) relate to bacterial homoserine lactonases.
    Bar-Rogovsky H; Hugenmatter A; Tawfik DS
    J Biol Chem; 2013 Aug; 288(33):23914-27. PubMed ID: 23788644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of biologically active δ-lactone eicosanoids as paraoxonase substrates.
    Teiber JF; Xiao J; Kramer GL; Ogawa S; Ebner C; Wolleb H; Carreira EM; Shih DM; Haley RW
    Biochem Biophys Res Commun; 2018 Oct; 505(1):87-92. PubMed ID: 30241945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
    Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
    Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human paraoxonase 1 as a pharmacologic agent: limitations and perspectives.
    Bajaj P; Tripathy RK; Aggarwal G; Pande AH
    ScientificWorldJournal; 2014; 2014():854391. PubMed ID: 25386619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase.
    Amitai G; Gaidukov L; Adani R; Yishay S; Yacov G; Kushnir M; Teitlboim S; Lindenbaum M; Bel P; Khersonsky O; Tawfik DS; Meshulam H
    FEBS J; 2006 May; 273(9):1906-19. PubMed ID: 16640555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonases (PON1, PON2, PON3) analyses in vitro and in vivo in relation to cardiovascular diseases.
    Aviram M; Rosenblat M
    Methods Mol Biol; 2008; 477():259-76. PubMed ID: 19082953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of organophosphorus hydrolase variants with high degradation activity towards organophosphate pesticides.
    Mee-Hie Cho C; Mulchandani A; Chen W
    Protein Eng Des Sel; 2006 Mar; 19(3):99-105. PubMed ID: 16423845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192.
    Aggarwal G; Prajapati R; Tripathy RK; Bajaj P; Iyengar AR; Sangamwar AT; Pande AH
    PLoS One; 2016; 11(2):e0147999. PubMed ID: 26829396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-D structure of serum paraoxonase 1 sheds light on its activity, stability, solubility and crystallizability.
    Harel M; Brumshtein B; Meged R; Dvir H; Ravelli RB; McCarthy A; Toker L; Silman I; Sussman JL
    Arh Hig Rada Toksikol; 2007 Sep; 58(3):347-53. PubMed ID: 17913690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.